🇮🇳IN
Sign In
IN

INDOUS

NSE

Indo Us Biotech Limited

₹66.50

+0.04(+0.06%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

INDOUS valuation summary

Indo Us Biotech Limited trades at 12.7 times trailing earnings. Return on equity is 15.3% and return on capital employed is 14.5%. That P/E equals an earnings yield of 7.9%. The median P/E across 51 listed Agricultural Inputs companies is 15.7, so Indo Us Biotech Limited trades at a 94% premium to that median.

P/E12.7
ROE15.3%
ROCE14.5%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer